Fulcrum Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FULC and other ETFs, options, and stocks.About FULC
Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF.
CEOAlexander C. Sapir
CEOAlexander C. Sapir
Employees45
Employees45
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2015
Founded2015
Employees45
Employees45
FULC Key Statistics
Market cap373.54M
Market cap373.54M
Price-Earnings ratio-105.01
Price-Earnings ratio-105.01
Dividend yield—
Dividend yield—
Average volume643.52K
Average volume643.52K
High today$6.95
High today$6.95
Low today$6.65
Low today$6.65
Open price$6.95
Open price$6.95
Volume145.72K
Volume145.72K
52 Week high$10.13
52 Week high$10.13
52 Week low$2.32
52 Week low$2.32
Analyst ratings
57%
of 7 ratingsBuy
57.1%
Hold
28.6%
Sell
14.3%
People also own
Based on the portfolios of people who own FULC. This list is generated using Robinhood data, and it’s not a recommendation.